Month: November 2018

Resolvin E1 may help treat gum disease and atherosclerosis

by

Researchers have shown that Resolvin E1 which is a molecule naturally produced in the body from an omega 3 fish oil, prevents and treats gum disease and decreases the likelihood for advanced arterial atherosclerotic plaques to rupture and form a thrombus or blood clot. Inflammation occurs with atherosclerosis and may play a role in the development of heart attacks and stroke. There is evidence from research groups that chronic inflammatory diseases such as diabetes, colitis, heart disease, Alzheimer’s disease, rheumatoid arthritis, kidney and pulmonary diseases, and cancer can benefit from the use of the pro-resolving lipid mediators such as resolvins and lipoxins. Researchers from Boston University and The Forsyth Institute used two groups of an experimental model that possessed highly inflamed advanced atherosclerosis. The first group was treated with a solution applied on gum tissues that contained an inflammation-lowering lipid … Read more

Chronic fatigue syndrome and Gulf War illness are distinct syndromes

by

Researchers at Georgetown University have found two distinct molecular signatures in the brain disorders chronic fatigue syndrome (CFS) and Gulf War Illness (GWI). In the past many doctors have told patients suffering from these syndromes that the disorders are psychological in origin so this news may come as useful to patients. The work also showed two variants of GWI. The two brain disorders share have many of the commonalities, such as fatigue, pain, exhaustion after exercise, and cognitive dysfunction. According to the National Academy of Medicine, chronic fatigue syndrome affects between 836,000 and 2.5 million Americans. The disorder was believed to be psychological in origin until a 2015 review of 9,000 articles pointed to unspecified biological causes.  Gulf War Illness has developed in more than one-fourth of the 697,000 veterans in the U.S. who were in the 1990-1991 Persian Gulf War. Gulf War … Read more